Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Melle

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Leukemia|July 25, 2021
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaAlessandra Rossi, Stefania Orecchioni, Paolo Falvo, et al.
Blood Advances|June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockadeValentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Oncoimmunology|February 24, 2025
Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancerRaffaello Roesel, Francesco Strati, Camilla Basso, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Cancers|September 28, 2021
Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell NeoplasmMaria Rosaria Sapienza, Giuseppe Benvenuto, Manuela Ferracin, et al.
Iscience|April 25, 2025
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphomaAlessandra Rossi, Saveria Mazzara, Dorotea Salemi, et al.
Molecular Cancer Research : MCR|January 29, 2017
Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell SarcomasMaria Antonella Laginestra, Claudio Tripodo, Claudio Agostinelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell LymphomaWaseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
Cancer|November 2, 2021
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphomaNicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Leukemia|July 25, 2021
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaAlessandra Rossi, Stefania Orecchioni, Paolo Falvo, et al.
Blood Advances|June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockadeValentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Oncoimmunology|February 24, 2025
Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancerRaffaello Roesel, Francesco Strati, Camilla Basso, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Cancers|September 28, 2021
Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell NeoplasmMaria Rosaria Sapienza, Giuseppe Benvenuto, Manuela Ferracin, et al.
Iscience|April 25, 2025
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphomaAlessandra Rossi, Saveria Mazzara, Dorotea Salemi, et al.
Molecular Cancer Research : MCR|January 29, 2017
Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell SarcomasMaria Antonella Laginestra, Claudio Tripodo, Claudio Agostinelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell LymphomaWaseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
Cancer|November 2, 2021
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphomaNicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Pageof 4